Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitri Volfson

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Brain : a Journal of Neurology|October 24, 2015
Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivityKelly R Bales, Sharon M O'Neill, Nikolay Pozdnyakov, et al.
JAMA Neurology|December 8, 2025
Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical TrialGert Jan Lammers, Giuseppe Plazzi, Emmanuel Mignot, et al.
Frontiers in Pharmacology|August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationRouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
NPJ Parkinson'S Disease|June 12, 2024
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 monthsJamie L Adams, Tairmae Kangarloo, Yishu Gong, et al.
Molecular and Cellular Neurosciences|July 30, 2013
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cellsMatthew F Burkhardt, Fernando J Martinez, Sarah Wright, et al.
NPJ Parkinson'S Disease|April 17, 2023
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD studyJamie L Adams, Tairmae Kangarloo, Brian Tracey, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Brain : a Journal of Neurology|October 24, 2015
Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivityKelly R Bales, Sharon M O'Neill, Nikolay Pozdnyakov, et al.
JAMA Neurology|December 8, 2025
Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical TrialGert Jan Lammers, Giuseppe Plazzi, Emmanuel Mignot, et al.
Frontiers in Pharmacology|August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationRouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
NPJ Parkinson'S Disease|June 12, 2024
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 monthsJamie L Adams, Tairmae Kangarloo, Yishu Gong, et al.
Molecular and Cellular Neurosciences|July 30, 2013
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cellsMatthew F Burkhardt, Fernando J Martinez, Sarah Wright, et al.
NPJ Parkinson'S Disease|April 17, 2023
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD studyJamie L Adams, Tairmae Kangarloo, Brian Tracey, et al.
Pageof 5